Global Tumor Genomics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 191351
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Tumor Genomics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Tumor Genomics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Tumor Genomics market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Tumor Genomics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Assays and Kits

Instrument

Market segment by Application, can be divided into

Diagnostics and Monitoring

Drug Discovery and Development

Biomarker Discovery

Market segment by players, this report covers

Abbott Laboratories

Agilent Technologies, Inc

Bio-Rad Laboratories, Inc.

Danaher Corporation

F. Hoffmann-La Roche Ltd

Fluidigm Corporation

General Electric Company

Illumina, Inc.

Merck KGaA

Myriad Genetics, Inc.

Pacific Biosciences of California, Inc.

PerkinElmer

QIAGEN

Siemens Healthineers AG

Thermo Fisher Scientific Inc.

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Tumor Genomics

1.2 Classification of Tumor Genomics by Type

1.2.1 Overview: Global Tumor Genomics Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Tumor Genomics Revenue Market Share by Type in 2020

1.2.3 Assays and Kits

1.2.4 Instrument

1.3 Global Tumor Genomics Market by Application

1.3.1 Overview: Global Tumor Genomics Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Diagnostics and Monitoring

1.3.3 Drug Discovery and Development

1.3.4 Biomarker Discovery

1.4 Global Tumor Genomics Market Size & Forecast

1.5 Global Tumor Genomics Market Size and Forecast by Region

1.5.1 Global Tumor Genomics Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Tumor Genomics Market Size by Region, (2016-2021)

1.5.3 North America Tumor Genomics Market Size and Prospect (2016-2026)

1.5.4 Europe Tumor Genomics Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Tumor Genomics Market Size and Prospect (2016-2026)

1.5.6 South America Tumor Genomics Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Tumor Genomics Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Tumor Genomics Market Drivers

1.6.2 Tumor Genomics Market Restraints

1.6.3 Tumor Genomics Trends Analysis

2 Company Profiles

2.1 Abbott Laboratories

2.1.1 Abbott Laboratories Details

2.1.2 Abbott Laboratories Major Business

2.1.3 Abbott Laboratories Tumor Genomics Product and Solutions

2.1.4 Abbott Laboratories Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Abbott Laboratories Recent Developments and Future Plans

2.2 Agilent Technologies, Inc

2.2.1 Agilent Technologies, Inc Details

2.2.2 Agilent Technologies, Inc Major Business

2.2.3 Agilent Technologies, Inc Tumor Genomics Product and Solutions

2.2.4 Agilent Technologies, Inc Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Agilent Technologies, Inc Recent Developments and Future Plans

2.3 Bio-Rad Laboratories, Inc.

2.3.1 Bio-Rad Laboratories, Inc. Details

2.3.2 Bio-Rad Laboratories, Inc. Major Business

2.3.3 Bio-Rad Laboratories, Inc. Tumor Genomics Product and Solutions

2.3.4 Bio-Rad Laboratories, Inc. Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Bio-Rad Laboratories, Inc. Recent Developments and Future Plans

2.4 Danaher Corporation

2.4.1 Danaher Corporation Details

2.4.2 Danaher Corporation Major Business

2.4.3 Danaher Corporation Tumor Genomics Product and Solutions

2.4.4 Danaher Corporation Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Danaher Corporation Recent Developments and Future Plans

2.5 F. Hoffmann-La Roche Ltd

2.5.1 F. Hoffmann-La Roche Ltd Details

2.5.2 F. Hoffmann-La Roche Ltd Major Business

2.5.3 F. Hoffmann-La Roche Ltd Tumor Genomics Product and Solutions

2.5.4 F. Hoffmann-La Roche Ltd Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 F. Hoffmann-La Roche Ltd Recent Developments and Future Plans

2.6 Fluidigm Corporation

2.6.1 Fluidigm Corporation Details

2.6.2 Fluidigm Corporation Major Business

2.6.3 Fluidigm Corporation Tumor Genomics Product and Solutions

2.6.4 Fluidigm Corporation Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Fluidigm Corporation Recent Developments and Future Plans

2.7 General Electric Company

2.7.1 General Electric Company Details

2.7.2 General Electric Company Major Business

2.7.3 General Electric Company Tumor Genomics Product and Solutions

2.7.4 General Electric Company Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 General Electric Company Recent Developments and Future Plans

2.8 Illumina, Inc.

2.8.1 Illumina, Inc. Details

2.8.2 Illumina, Inc. Major Business

2.8.3 Illumina, Inc. Tumor Genomics Product and Solutions

2.8.4 Illumina, Inc. Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Illumina, Inc. Recent Developments and Future Plans

2.9 Merck KGaA

2.9.1 Merck KGaA Details

2.9.2 Merck KGaA Major Business

2.9.3 Merck KGaA Tumor Genomics Product and Solutions

2.9.4 Merck KGaA Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Merck KGaA Recent Developments and Future Plans

2.10 Myriad Genetics, Inc.

2.10.1 Myriad Genetics, Inc. Details

2.10.2 Myriad Genetics, Inc. Major Business

2.10.3 Myriad Genetics, Inc. Tumor Genomics Product and Solutions

2.10.4 Myriad Genetics, Inc. Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Myriad Genetics, Inc. Recent Developments and Future Plans

2.11 Pacific Biosciences of California, Inc.

2.11.1 Pacific Biosciences of California, Inc. Details

2.11.2 Pacific Biosciences of California, Inc. Major Business

2.11.3 Pacific Biosciences of California, Inc. Tumor Genomics Product and Solutions

2.11.4 Pacific Biosciences of California, Inc. Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Pacific Biosciences of California, Inc. Recent Developments and Future Plans

2.12 PerkinElmer

2.12.1 PerkinElmer Details

2.12.2 PerkinElmer Major Business

2.12.3 PerkinElmer Tumor Genomics Product and Solutions

2.12.4 PerkinElmer Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 PerkinElmer Recent Developments and Future Plans

2.13 QIAGEN

2.13.1 QIAGEN Details

2.13.2 QIAGEN Major Business

2.13.3 QIAGEN Tumor Genomics Product and Solutions

2.13.4 QIAGEN Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 QIAGEN Recent Developments and Future Plans

2.14 Siemens Healthineers AG

2.14.1 Siemens Healthineers AG Details

2.14.2 Siemens Healthineers AG Major Business

2.14.3 Siemens Healthineers AG Tumor Genomics Product and Solutions

2.14.4 Siemens Healthineers AG Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Siemens Healthineers AG Recent Developments and Future Plans

2.15 Thermo Fisher Scientific Inc.

2.15.1 Thermo Fisher Scientific Inc. Details

2.15.2 Thermo Fisher Scientific Inc. Major Business

2.15.3 Thermo Fisher Scientific Inc. Tumor Genomics Product and Solutions

2.15.4 Thermo Fisher Scientific Inc. Tumor Genomics Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Tumor Genomics Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Tumor Genomics Players Market Share

3.2.2 Top 10 Tumor Genomics Players Market Share

3.2.3 Market Competition Trend

3.3 Tumor Genomics Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Tumor Genomics Revenue and Market Share by Type (2016-2021)

4.2 Global Tumor Genomics Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Tumor Genomics Revenue Market Share by Application (2016-2021)

5.2 Tumor Genomics Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Tumor Genomics Revenue by Type (2016-2026)

6.2 North America Tumor Genomics Revenue by Application (2016-2026)

6.3 North America Tumor Genomics Market Size by Country

6.3.1 North America Tumor Genomics Revenue by Country (2016-2026)

6.3.2 United States Tumor Genomics Market Size and Forecast (2016-2026)

6.3.3 Canada Tumor Genomics Market Size and Forecast (2016-2026)

6.3.4 Mexico Tumor Genomics Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Tumor Genomics Revenue by Type (2016-2026)

7.2 Europe Tumor Genomics Revenue by Application (2016-2026)

7.3 Europe Tumor Genomics Market Size by Country

7.3.1 Europe Tumor Genomics Revenue by Country (2016-2026)

7.3.2 Germany Tumor Genomics Market Size and Forecast (2016-2026)

7.3.3 France Tumor Genomics Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Tumor Genomics Market Size and Forecast (2016-2026)

7.3.5 Russia Tumor Genomics Market Size and Forecast (2016-2026)

7.3.6 Italy Tumor Genomics Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Tumor Genomics Revenue by Type (2016-2026)

8.2 Asia-Pacific Tumor Genomics Revenue by Application (2016-2026)

8.3 Asia-Pacific Tumor Genomics Market Size by Region

8.3.1 Asia-Pacific Tumor Genomics Revenue by Region (2016-2026)

8.3.2 China Tumor Genomics Market Size and Forecast (2016-2026)

8.3.3 Japan Tumor Genomics Market Size and Forecast (2016-2026)

8.3.4 South Korea Tumor Genomics Market Size and Forecast (2016-2026)

8.3.5 India Tumor Genomics Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Tumor Genomics Market Size and Forecast (2016-2026)

8.3.7 Australia Tumor Genomics Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Tumor Genomics Revenue by Type (2016-2026)

9.2 South America Tumor Genomics Revenue by Application (2016-2026)

9.3 South America Tumor Genomics Market Size by Country

9.3.1 South America Tumor Genomics Revenue by Country (2016-2026)

9.3.2 Brazil Tumor Genomics Market Size and Forecast (2016-2026)

9.3.3 Argentina Tumor Genomics Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Tumor Genomics Revenue by Type (2016-2026)

10.2 Middle East & Africa Tumor Genomics Revenue by Application (2016-2026)

10.3 Middle East & Africa Tumor Genomics Market Size by Country

10.3.1 Middle East & Africa Tumor Genomics Revenue by Country (2016-2026)

10.3.2 Turkey Tumor Genomics Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Tumor Genomics Market Size and Forecast (2016-2026)

10.3.4 UAE Tumor Genomics Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Tumor Genomics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Tumor Genomics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Tumor Genomics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Tumor Genomics Revenue (USD Million) by Region (2016-2021)

Table 5. Global Tumor Genomics Revenue Market Share by Region (2021-2026)

Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors

Table 7. Abbott Laboratories Major Business

Table 8. Abbott Laboratories Tumor Genomics Product and Solutions

Table 9. Abbott Laboratories Tumor Genomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Agilent Technologies, Inc Corporate Information, Head Office, and Major Competitors

Table 11. Agilent Technologies, Inc Major Business

Table 12. Agilent Technologies, Inc Tumor Genomics Product and Solutions

Table 13. Agilent Technologies, Inc Tumor Genomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Bio-Rad Laboratories, Inc. Corporate Information, Head Office, and Major Competitors

Table 15. Bio-Rad Laboratories, Inc. Major Business

Table 16. Bio-Rad Laboratories, Inc. Tumor Genomics Product and Solutions

Table 17. Bio-Rad Laboratories, Inc. Tumor Genomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Danaher Corporation Corporate Information, Head Office, and Major Competitors

Table 19. Danaher Corporation Major Business

Table 20. Danaher Corporation Tumor Genomics Product and Solutions

Table 21. Danaher Corporation Tumor Genomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. F. Hoffmann-La Roche Ltd Corporate Information, Head Office, and Major Competitors

Table 23. F. Hoffmann-La Roche Ltd Major Business

Table 24. F. Hoffmann-La Roche Ltd Tumor Genomics Product and Solutions

Table 25. F. Hoffmann-La Roche Ltd Tumor Genomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Fluidigm Corporation Corporate Information, Head Office, and Major Competitors

Table 27. Fluidigm Corporation Major Business

Table 28. Fluidigm Corporation Tumor Genomics Product and Solutions

Table 29. Fluidigm Corporation Tumor Genomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. General Electric Company Corporate Information, Head Office, and Major Competitors

Table 31. General Electric Company Major Business

Table 32. General Electric Company Tumor Genomics Product and Solutions

Table 33. General Electric Company Tumor Genomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Illumina, Inc. Corporate Information, Head Office, and Major Competitors

Table 35. Illumina, Inc. Major Business

Table 36. Illumina, Inc. Tumor Genomics Product and Solutions

Table 37. Illumina, Inc. Tumor Genomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Merck KGaA Corporate Information, Head Office, and Major Competitors

Table 39. Merck KGaA Major Business

Table 40. Merck KGaA Tumor Genomics Product and Solutions

Table 41. Merck KGaA Tumor Genomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Myriad Genetics, Inc. Corporate Information, Head Office, and Major Competitors

Table 43. Myriad Genetics, Inc. Major Business

Table 44. Myriad Genetics, Inc. Tumor Genomics Product and Solutions

Table 45. Myriad Genetics, Inc. Tumor Genomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Pacific Biosciences of California, Inc. Corporate Information, Head Office, and Major Competitors

Table 47. Pacific Biosciences of California, Inc. Major Business

Table 48. Pacific Biosciences of California, Inc. Tumor Genomics Product and Solutions

Table 49. Pacific Biosciences of California, Inc. Tumor Genomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. PerkinElmer Corporate Information, Head Office, and Major Competitors

Table 51. PerkinElmer Major Business

Table 52. PerkinElmer Tumor Genomics Product and Solutions

Table 53. PerkinElmer Tumor Genomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. QIAGEN Corporate Information, Head Office, and Major Competitors

Table 55. QIAGEN Major Business

Table 56. QIAGEN Tumor Genomics Product and Solutions

Table 57. QIAGEN Tumor Genomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Siemens Healthineers AG Corporate Information, Head Office, and Major Competitors

Table 59. Siemens Healthineers AG Major Business

Table 60. Siemens Healthineers AG Tumor Genomics Product and Solutions

Table 61. Siemens Healthineers AG Tumor Genomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Thermo Fisher Scientific Inc. Corporate Information, Head Office, and Major Competitors

Table 63. Thermo Fisher Scientific Inc. Major Business

Table 64. Thermo Fisher Scientific Inc. Tumor Genomics Product and Solutions

Table 65. Thermo Fisher Scientific Inc. Tumor Genomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Global Tumor Genomics Revenue (USD Million) by Players (2019-2021)

Table 67. Global Tumor Genomics Revenue Share by Players (2019-2021)

Table 68. Breakdown of Tumor Genomics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. Tumor Genomics Players Head Office, Products and Services Provided

Table 70. Tumor Genomics Mergers & Acquisitions in the Past Five Years

Table 71. Tumor Genomics New Entrants and Expansion Plans

Table 72. Global Tumor Genomics Revenue (USD Million) by Type (2016-2021)

Table 73. Global Tumor Genomics Revenue Share by Type (2016-2021)

Table 74. Global Tumor Genomics Revenue Forecast by Type (2021-2026)

Table 75. Global Tumor Genomics Revenue by Application (2016-2021)

Table 76. Global Tumor Genomics Revenue Forecast by Application (2021-2026)

Table 77. North America Tumor Genomics Revenue by Type (2016-2021) & (USD Million)

Table 78. North America Tumor Genomics Revenue by Type (2021-2026) & (USD Million)

Table 79. North America Tumor Genomics Revenue by Application (2016-2021) & (USD Million)

Table 80. North America Tumor Genomics Revenue by Application (2021-2026) & (USD Million)

Table 81. North America Tumor Genomics Revenue by Country (2016-2021) & (USD Million)

Table 82. North America Tumor Genomics Revenue by Country (2021-2026) & (USD Million)

Table 83. Europe Tumor Genomics Revenue by Type (2016-2021) & (USD Million)

Table 84. Europe Tumor Genomics Revenue by Type (2021-2026) & (USD Million)

Table 85. Europe Tumor Genomics Revenue by Application (2016-2021) & (USD Million)

Table 86. Europe Tumor Genomics Revenue by Application (2021-2026) & (USD Million)

Table 87. Europe Tumor Genomics Revenue by Country (2016-2021) & (USD Million)

Table 88. Europe Tumor Genomics Revenue by Country (2021-2026) & (USD Million)

Table 89. Asia-Pacific Tumor Genomics Revenue by Type (2016-2021) & (USD Million)

Table 90. Asia-Pacific Tumor Genomics Revenue by Type (2021-2026) & (USD Million)

Table 91. Asia-Pacific Tumor Genomics Revenue by Application (2016-2021) & (USD Million)

Table 92. Asia-Pacific Tumor Genomics Revenue by Application (2021-2026) & (USD Million)

Table 93. Asia-Pacific Tumor Genomics Revenue by Region (2016-2021) & (USD Million)

Table 94. Asia-Pacific Tumor Genomics Revenue by Region (2021-2026) & (USD Million)

Table 95. South America Tumor Genomics Revenue by Type (2016-2021) & (USD Million)

Table 96. South America Tumor Genomics Revenue by Type (2021-2026) & (USD Million)

Table 97. South America Tumor Genomics Revenue by Application (2016-2021) & (USD Million)

Table 98. South America Tumor Genomics Revenue by Application (2021-2026) & (USD Million)

Table 99. South America Tumor Genomics Revenue by Country (2016-2021) & (USD Million)

Table 100. South America Tumor Genomics Revenue by Country (2021-2026) & (USD Million)

Table 101. Middle East & Africa Tumor Genomics Revenue by Type (2016-2021) & (USD Million)

Table 102. Middle East & Africa Tumor Genomics Revenue by Type (2021-2026) & (USD Million)

Table 103. Middle East & Africa Tumor Genomics Revenue by Application (2016-2021) & (USD Million)

Table 104. Middle East & Africa Tumor Genomics Revenue by Application (2021-2026) & (USD Million)

Table 105. Middle East & Africa Tumor Genomics Revenue by Country (2016-2021) & (USD Million)

Table 106. Middle East & Africa Tumor Genomics Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Tumor Genomics Picture

Figure 2. Global Tumor Genomics Revenue Market Share by Type in 2020

Figure 3. Assays and Kits

Figure 4. Instrument

Figure 5. Tumor Genomics Revenue Market Share by Application in 2020

Figure 6. Diagnostics and Monitoring Picture

Figure 7. Drug Discovery and Development Picture

Figure 8. Biomarker Discovery Picture

Figure 9. Global Tumor Genomics Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 10. Global Tumor Genomics Revenue and Forecast (2016-2026) & (USD Million)

Figure 11. Global Tumor Genomics Revenue Market Share by Region (2016-2026)

Figure 12. Global Tumor Genomics Revenue Market Share by Region in 2020

Figure 13. North America Tumor Genomics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Europe Tumor Genomics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Asia-Pacific Tumor Genomics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. South America Tumor Genomics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Middle East and Africa Tumor Genomics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Tumor Genomics Market Drivers

Figure 19. Tumor Genomics Market Restraints

Figure 20. Tumor Genomics Market Trends

Figure 21. Abbott Laboratories Recent Developments and Future Plans

Figure 22. Agilent Technologies, Inc Recent Developments and Future Plans

Figure 23. Bio-Rad Laboratories, Inc. Recent Developments and Future Plans

Figure 24. Danaher Corporation Recent Developments and Future Plans

Figure 25. F. Hoffmann-La Roche Ltd Recent Developments and Future Plans

Figure 26. Fluidigm Corporation Recent Developments and Future Plans

Figure 27. General Electric Company Recent Developments and Future Plans

Figure 28. Illumina, Inc. Recent Developments and Future Plans

Figure 29. Merck KGaA Recent Developments and Future Plans

Figure 30. Myriad Genetics, Inc. Recent Developments and Future Plans

Figure 31. Pacific Biosciences of California, Inc. Recent Developments and Future Plans

Figure 32. PerkinElmer Recent Developments and Future Plans

Figure 33. QIAGEN Recent Developments and Future Plans

Figure 34. Siemens Healthineers AG Recent Developments and Future Plans

Figure 35. Thermo Fisher Scientific Inc. Recent Developments and Future Plans

Figure 36. Global Tumor Genomics Revenue Share by Players in 2020

Figure 37. Tumor Genomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 38. Global Top 3 Players Tumor Genomics Revenue Market Share in 2020

Figure 39. Global Top 10 Players Tumor Genomics Revenue Market Share in 2020

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 41. Global Tumor Genomics Revenue Share by Type in 2020

Figure 42. Global Tumor Genomics Market Share Forecast by Type (2021-2026)

Figure 43. Global Tumor Genomics Revenue Share by Application in 2020

Figure 44. Global Tumor Genomics Market Share Forecast by Application (2021-2026)

Figure 45. North America Tumor Genomics Sales Market Share by Type (2016-2026)

Figure 46. North America Tumor Genomics Sales Market Share by Application (2016-2026)

Figure 47. North America Tumor Genomics Revenue Market Share by Country (2016-2026)

Figure 48. United States Tumor Genomics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Canada Tumor Genomics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Mexico Tumor Genomics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Europe Tumor Genomics Sales Market Share by Type (2016-2026)

Figure 52. Europe Tumor Genomics Sales Market Share by Application (2016-2026)

Figure 53. Europe Tumor Genomics Revenue Market Share by Country (2016-2026)

Figure 54. Germany Tumor Genomics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. France Tumor Genomics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. United Kingdom Tumor Genomics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Russia Tumor Genomics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Italy Tumor Genomics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Asia-Pacific Tumor Genomics Sales Market Share by Type (2016-2026)

Figure 60. Asia-Pacific Tumor Genomics Sales Market Share by Application (2016-2026)

Figure 61. Asia-Pacific Tumor Genomics Revenue Market Share by Region (2016-2026)

Figure 62. China Tumor Genomics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Japan Tumor Genomics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. South Korea Tumor Genomics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. India Tumor Genomics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Southeast Asia Tumor Genomics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Australia Tumor Genomics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. South America Tumor Genomics Sales Market Share by Type (2016-2026)

Figure 69. South America Tumor Genomics Sales Market Share by Application (2016-2026)

Figure 70. South America Tumor Genomics Revenue Market Share by Country (2016-2026)

Figure 71. Brazil Tumor Genomics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Argentina Tumor Genomics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Middle East and Africa Tumor Genomics Sales Market Share by Type (2016-2026)

Figure 74. Middle East and Africa Tumor Genomics Sales Market Share by Application (2016-2026)

Figure 75. Middle East and Africa Tumor Genomics Revenue Market Share by Country (2016-2026)

Figure 76. Turkey Tumor Genomics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Saudi Arabia Tumor Genomics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. UAE Tumor Genomics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz